Notice of 111th Annual General Meeting
September 27, 2023
Notice is hereby given that the 111th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
Notice is hereby given that the 111th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 31,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession,
Notice is hereby given that the 110th Annual General Meeting of Pharmaceutical Defence Limited will be a hybrid meeting, both in person at Suite 3,
The following vacancies will occur as of the date of the next Annual General Meeting to be held on 20 October 2022 One Director
Following the retirement of Curtis Ruhnau, PDL is pleased to announce the appointment of Amanda Galbraith as the new Director for NSW and the ACT.
Due to the impending retirement of Curtis Ruhnau, expressions of interest are invited by PDL for the position of Director for New South Wales (with
Pharmaceutical Defence Limited (PDL) is a member owned organisation supporting around 30,000 pharmacist members and the pharmacy profession. The leading risk advisors to the profession,
The PDL Director elections for the New South Wales and Australian Capital Territory seat as well as for Western Australia were held recently, with the
Notice is hereby given that the 109th Annual General Meeting (AGM) of Pharmaceutical Defence Limited will be a Microsoft Teams Meeting on Thursday, the 21st
We have had another successful membership renewal, with ongoing loyalty demonstrated by our more than 28,000 members. PDL Chair, Paul Naismith, said “We were delighted